Guardant Health and Boehringer Ingelheim Join Forces to Develop Guardant360 CDx for Zongertinib Companion Diagnostic
US-based precision oncology specialist Guardant Health, Inc. (NASDAQ: GH) has entered into an agreement with...
US-based precision oncology specialist Guardant Health, Inc. (NASDAQ: GH) has entered into an agreement with...
Sino-US biopharma AnHeart Therapeutics and US precision oncology firm Guardant Health Inc. (NASDAQ: GH) have...
China-based Adicon Holdings Limited announced a strategic partnership with U.S. firm Guardant Health, Inc. (NASDAQ:...